A Study of ALG-055009 in Healthy Volunteers and Subjects With Hyperlipidemia

Clinical trial NCT05090111 · COMPLETED

Trial details

NCT number: NCT05090111
Sponsor: Aligos Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

NASH - Nonalcoholic Steatohepatitis

Start date: 2021-12-01
Primary completion: 2023-06-16
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.